Alto Neuroscience (ANRO) insider trading in the last 6 months

Form 4 filings, newest first

Quality Score today -6

One insider sold $3.6M. No buys.

SellNicholas Conrad Smith$2.9MPresident and CFOat $26.58 on Sep 29, filed Oct 1

SellNicholas Conrad SmithPresident and CFO$2.9Mat $26.58 on Sep 29, filed Oct 1

SellNicholas Conrad Smith$597KPresident and CFOat $25.78 on Sep 30, filed Oct 1

SellNicholas Conrad SmithPresident and CFO$597Kat $25.78 on Sep 30, filed Oct 1

SellNicholas Conrad Smith$24KPresident and CFOat $26.87 on Sep 30, filed Oct 1

SellNicholas Conrad SmithPresident and CFO$24Kat $26.87 on Sep 30, filed Oct 1

From SEC Form 4s, the newest filed Oct 1, 2026 · Insiders have 2 business days to file a trade

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 3 tradesSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Pro members see every filing on ANRO with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Alto Neuroscience

Nicholas Conrad SmithPresident and CFO · 3 sales

Insider trades by person

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Questions about ANRO's insider trades

As of Nov 2, 2026: Alto Neuroscience (ANRO) has 3 insider filings on record in the last 6 months, the newest filed Oct 1, 2026. Its Quality Score is -6 (Poor). Scores as of 6:18 PM ET, 15 minutes behind.

Are ANRO insiders buying or selling?

One insider sold $3.6M across 3 filings in the last 6 months. No open-⁠market buys on record. The newest filing: Nicholas Conrad Smith, President and CFO, sold $2.9M on Sep 29, 2026.

Who are ANRO's biggest insider sellers?

The one insider who sold ANRO in the last 6 months: Nicholas Conrad Smith (President and CFO), 3 sales.

When did an ANRO insider last buy?

No ANRO insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Nicholas Conrad Smith on Sep 29, 2026.

Alto Neuroscience's page has its Quality Score, its chart, and its earnings. More in Healthcare and Pharma.